Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
English Section

Polish scientists develop strong new painkiller

09.07.2019 16:44
Researchers from the Faculty of Chemistry at the University of Warsaw have developed a new chemical compound with analgesic properties 5,000 times more effective than currently available painkillers, the university has said.
jarmoluk/pixabay.com CC0 Creative Commons

Administering the compound causes the body to simultaneously send a signal inhibiting and relieving pain and a second signal extinguishing its source, according to the researchers.

Dr. Rafał Wieczorek, a member of the research team, said: "This is a huge advantage over previously known painkillers because they all work in either one way or the other, while none of them works both ways at the same time."

The compound is a peptidomimetic; one part of the molecule affects opioid receptors, which causes pain relief, while the other part acts on the melanocortin 4 receptor, which is responsible for sending a signal initiating pain, according to the researchers.

They say the substance could be used in neuropathic pain relief, acute trauma or palliative treatment. Currently used opioids, such as morphine, effectively relieve pain, but show addictive properties and have severe side effects.

The new substance can be used at a concentration several thousand times smaller than morphine to eliminate pain completely even if it is the result of damaged or irritated nerves, the university said.

The research team is working on the first phase of clinical trials, while planning to seek patent protection for the medicine in Poland and selected other countries around the world.


Source: PAP